SHARE
Veterinary Healthcare Market

Veterinary Healthcare Market Forecasts to 2028 – Global Analysis By Animal Type (Companion Animals, Livestock Animals), Disease (Arthritis, Allergies, Dermatology Cases, Gastrointestinal Diseases) and By Geography

4.9 (67 reviews)
Published: February 2022 ID: SMRC19611
4.9 (67 reviews)
Published: February 2022 ID: SMRC19611

This report covers the impact of COVID-19 on this global market

According to Stratistics MRC, the Global Veterinary Healthcare Market is accounted for $33.96 billion in 2021 and is expected to reach $65.76 billion by 2028 growing at a CAGR of 9.9% during the forecast period. Veterinary healthcare can be defined as the science associated with the diagnosis, treatment, and prevention of diseases in animals.  The scope of veterinary healthcare is broad covering various animal species both domestic and wild.

Market Dynamics:

Driver:

Introduction of new policies


Introduction of new policies to pet owners is significantly influencing the demand of veterinary healthcare market. In the developed market, the penetration rate of pet insurance policies is very high. For instance, in the United States, the need for pet insurance policies is growing at a high CAGR during the forecast period. Similarly, in the UK, the penetration rate of pet insurance is 20%. The introduction of various pet insurance policies is solely increasing visits to veterinary healthcare centers or clinics.

Restraint:

Shortage of veterinarians


There is a decreasing number of veterinarians due to fewer training programs. Reluctance to adopt new technologies in undeveloped countries is a significant attribute for veterinarians' shortage in these places. Stringent rules and regulations are a significant challenge. Government authorities are imposing strict rules and regulations to approve a vaccine. It remains a major challenging factor for the key players. Some vaccines are unavailable against livestock vector-borne pathogens is hampering the growth rate of the market.

Opportunity:

Increasing investments in veterinary hospitals


Increasing investments in veterinary hospitals to ensure quality services is a significant factor anticipated to present growth opportunities for the market. The rise in the concern towards animal healthcare is lavishing the demand of the veterinary healthcare market. Also, growing incidence of various health disorders among animals are ascribed to bolster the market's need. Pet lovers seek for best treatment procedure at any cost, which is also impacting the growth of the market towards positive. Increasing the livestock population is another attribute focused on expanding the demand of the market. Furthermore, people's need for quality poultry products for a healthy lifestyle is likely to extensively outshine the market's need.

Threat:

Fluctuations in the availability of raw materials


Fluctuations in the availability of raw materials and the unavailability of vaccines for some diseases restrict the market's demand. Additionally, increasing regulation on antibiotics is expected to remain a major challenge for the market. Apart from that, growing costs regulation related to animal testing is also a significant hurdle for the growth of the veterinary healthcare market.

The livestock animals segment is expected to be the largest during the forecast period

Livestock animals such as cattle and poultry are expected to experience higher medicalization rates during the forecast years. In emerging economies such as the Philippines and Vietnam, earlier, poultry health was neglected, and owners used to discard the chickens in bulk during a virus outbreak. Similar was the condition of a few cattle farms. Unorganized farms were often neglected, and that hampered the overall meat production in such countries. However, the current laws have been framed to scrutinize the situation in farms and ensure maximum animal protection.

The therapeutics/drugs segment is expected to have the highest CAGR during the forecast period

Therapeutics/drugs segment comprises of vaccines too.Vaccines are comprised of viruses, bacteria, or other disease-causing organisms that have been killed or altered so that they cannot cause any disease, thus, boosting immunity. Vaccines are being manufactured that contain genetically engineered components derived from those disease agents.

Region with largest share:

North America is projected to hold the largest market share owing to the increasing chronic diseases among animals. The US is the leading country with the highest shares of the market. The introduction of pet insurance policies and creating awareness over the availability of the different treatment processes for pet animals are anticipated to fuel the market's growth rate. Increasing expenditure on veterinary healthcare in the US is solely accelerating the market demand. Some people also treat animals as family members in these countries, hugely impacting the market's growth rate.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR due to the rise in the support from the government organizations through funds and focus on developing new drugs or vaccines in favor of the end-user.

Key players in the market

Some of the key players profiled in the Veterinary Healthcare Market include Novartis, International AG, Eli Lilly and Company, Bayer Healthcare, Koninklijke DSM N.V, Sanofi-Aventis, MSD Animal Health, Cargill Inc, SeQuent Scientific Ltd, Boehringer Ingelheim , International GmbH, Nutreco N.V., Phibro Animal Health, Elanco Animal Health, Ceva Animal Health Inc, Merck Ltd, and Zoetis Animal Healthcare.

Key developments:

In June 2020: Merck completed the acquisition of a Quantified Ag leading data analytics company that monitors cattle temperature and helps in the early detection of any disease. This acquisition will diversify Merck’s veterinary product offerings and will positively impact the company’s profitability.

In February 2020: Zoetis acquired Ethos Diagnostic Science. This acquisition will not only expand company’s product portfolio but will also help the company to grow exponentially in the veterinary space.

In January 2020: Boehringer Ingelheim’s launched a vaccine, VAXXITEK HVT+IBD+ND, that provides a strong immune foundation and optimized protection against Marek's Disease, Infectious Bursal Disease (classic and variant types), and Newcastle Disease.

Types Covered:
• Veterinary Services
• Animal Medicine
• Veterinary Medical Equipment

Animal Types Covered:
• Companion Animals
• Livestock Animals

Treatments Covered:
• Arthritis
• Allergies
• Dermatology Cases
• Gastrointestinal Diseases

Products Covered:
• Diagnostic Tools
• Therapeutics/Drugs

End Users Covered:
• Veterinary Hospitals
• Veterinary Clinics
• Veterinary Laboratory Testing Services
• Pharmacies

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan       
o China       
o India       
o Australia 
o New Zealand
o South Korea
o Rest of Asia Pacific   
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Select License Type

Allows one person to have access to the ordered product.The ordered product cannot be distributed to anyone else.
Allows the ordered product to be shared among a maximum of 5 people within your organisation.
Allows the product to be shared among all employees of your organisation at one particular location.
Allows the product to be shared among all employees of your organisation regardless of their geographical location.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials